Banner University Arizona Cancer Center North Campus 3838 N Campbell Ave, Tucson, AZ 85719 (520)6942873 (phone), (520)6940255 (fax)
Education:
Medical School University of Virginia School of Medicine Graduated: 1966
Languages:
English Spanish
Description:
Dr. Alberts graduated from the University of Virginia School of Medicine in 1966. He works in Tucson, AZ and specializes in Gynecologic Oncology. Dr. Alberts is affiliated with Banner University Medical Center and Banner University Medical Center South Campus.
Martin Stogniew - Blue Bell PA David S. Alberts - Tucson AZ Edward H. Kaplan - Skokie IL
Assignee:
MedImmune Oncology, Inc. - Gaithersburg MD
International Classification:
A61K 3166
US Classification:
514665, 514114, 514649, 514608, 514706
Abstract:
The present invention relates to new uses of S-2-(3-aminopropylamino)ethyl dihydrogen phosphorothioate, (amifostine) and other aminothiol compounds to treat and reverse toxicities caused by therapeutic agents, radiation treatment or diabetes. In particular, the invention provides a method for treating neurotoxicity and nephrotoxicity associated with the administration of chemotherapeutic agents.
Methods For The Treatment Of Neuro- Disorders Using Aminothiol Compounds
The present invention relates to new uses of S-2-(3-aminopropylamino)ethyl dihydrogen phosphorothioate, (amifostine) and other aminothiol compounds to treat and reverse toxicities caused by therapeutic agents, radiation treatment or diabetes. In particular, the invention provides a method for treating neurotoxicity and nephrotoxicity associated with the administration of chemotherapeutic agents.
Martin Stogniew - Blue Bell PA, US David Alberts - Tucson AZ, US Edward Kaplan - Skokie IL, US
International Classification:
A61K 31/13 A61K 31/66
US Classification:
514114000, 514665000
Abstract:
The present invention relates to new uses of thermally stable, crystalline S-2-(3-aminopropylamino)ethyl dihydrogen phosphorothioate, (amifostine) and other aminothiol compounds to treat and reverse toxicities caused by radiation treatment. In particular, the invention provides a method for treating or preventing xerostomia associated with the administration of radiation treatment of head and neck cancer.
Methods For Treatment Of Neuro- And Nephro- Disorders And Therapeutic Toxicities Using Aminothiol Compounds
Martin Stogniew - Blue Bell PA, US David Alberts - Tucson AZ, US Edward Kaplan - Skokie IL, US
International Classification:
A61K 31/66 A61K 31/13
US Classification:
514114000, 514665000
Abstract:
The present invention relates to new uses of S-2-(3-aminopropylamino)ethyl dihydrogen phosphorothioate, (amifostine) and other aminothiol compounds to treat and reverse toxicities caused by therapeutic agents, radiation treatment or diabetes. In particular, the invention provides a method for treating neurotoxicity and nephrotoxicity associated with the administration of chemotherapeutic agents.
Martin STOGNIEW - Blue Bell PA, US David S. ALBERTS - Tucson AZ, US Edward H. KAPLAN - Skokie IL, US
International Classification:
A61K 31/661 A61P 35/00
US Classification:
514114
Abstract:
The present invention relates to new uses of thermally stable, crystalline S-2-(3-aminopropylamino)ethyl dihydrogen phosphorothioate, (amifostine) and other aminothiol compounds to treat and reverse toxicities caused by radiation treatment. In particular, the invention provides a method for treating or preventing xerostomia associated with the administration of radiation treatment of head and neck cancer.
Methods For Treatment Of Neuro--And Nephro--Disorders And Therapeutic Toxicities Using Aminothiol Compounds
Martin Stogniew - Blue Bell PA David S. Alberts - Tucson AZ Edward H. Kaplan - Skokie IL
Assignee:
U.S. Bioscience, Inc. - West Conshohocken PA The Arizona Board of Regents on behalf of the University of Arizona - Tuscon AZ
International Classification:
A01N 3808 A01N 5700 A01N 3302
US Classification:
514665
Abstract:
The present invention relates to new uses of S-2-(3-aminopropylamino)ethyl dihydrogen phosphorothioate, (amifostine) and other aminothiol compounds to treat and reverse toxicities caused by therapeutic agents, radiation treatment or diabetes. In particular, the invention provides a method for treating neurotoxicity and nephrotoxicity associated with the administration of chemotherapeutic agents.
David Stephen Alberts (1942) is an American Director of Research for the Office of the Assistant Secretary of Defense (OASD) for Networks and Information ...
Lincoln School New Providence NJ 1965-1967, Cunniff Elementary School Watertown MA 1966-1966, Parker School Watertown MA 1967-1968, West Junior High School Watertown MA 1968-1970